Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics

被引：0
|
作者：
Vataire, A. [1 ]
Ferchichi, S. [1 ]
Desroziers, K. [1 ]
Cadi-Soussi, N. [2 ]
Murthy, V. [3 ]
Toumi, M. [4 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Takeda Pharmaceut Int GmbH, Zurich, Switzerland
[3] Takeda Dev Ctr Europe, London, England
[4] Univ Lyon 1, F-69365 Lyon, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70785-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.007
引用
收藏
页码：S495 / S495
页数：1
相关论文
共 50 条
  • [1] Metabolic risk reduction in patients with schizophrenia treated with antipsychotics: recommendations of the Polish Psychiatric Association
    Wichniak, Adam
    Dudek, Dominika
    Heitzman, Janusz
    Kaplon-Cieslicka, Agnieszka
    Mamcarz, Artur
    Samochowiec, Jerzy
    Szulc, Agata
    Bienkowski, Przemyslaw
    PSYCHIATRIA POLSKA, 2019, 53 (06) : 1191 - 1218
  • [2] Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community
    Mackin, Paul
    Bishop, David
    Watkinson, Helen
    Gallagher, Peter
    Ferrier, I. Nicol
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : 23 - 29
  • [3] Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study
    Bobes, Julio
    Arango, Celso
    Aranda, Pedro
    Carmena, Rafael
    Garcia-Garcia, Margarida
    Rejas, Javier
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 162 - 173
  • [4] Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Said, Mas Ayu
    Sulaiman, Ahmad Hatim
    Habil, Mohd Hussain
    Das, Srijit
    Abu Bakar, Abdul Kadir
    Yusoff, Rosliwati Md
    Loo, Tsui Huei
    Abu Bakar, Shamshunnisah
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (12) : 801 - 807
  • [5] Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics
    Bai, Ya Mei
    Chen, Tzu-Ting
    Liou, Ying-Jay
    Hong, Chen-Jee
    Tsai, Shih-Jen
    SCHIZOPHRENIA RESEARCH, 2011, 125 (2-3) : 179 - 186
  • [6] Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
    Fang, Xinyu
    Wang, Yewei
    Chen, Yan
    Ren, Juanjuan
    Zhang, Chen
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2161 - 2170
  • [7] Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach
    Shulman, Matisyahu
    Miller, Avraham
    Misher, Jason
    Tentler, Aleksey
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2014, 7 : 489 - 501
  • [8] Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics
    Yang, Lin
    Chen, Jianhua
    Li, Yan
    Wang, Yan
    Liang, Shiqiao
    Shi, Yongyong
    Shi, Shenxun
    Xu, Yifeng
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (06): : 467 - 474
  • [9] Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
    Koricanac, Aleksandra
    Lucic, Aleksandra Tomic
    Veselinovic, Mirjana
    Sretenovic, Danijela Bazic
    Bucic, Gorica
    Azanjac, Anja
    Radmanovic, Olivera
    Matovic, Mirjana
    Stanojevic, Marijana
    Skevin, Aleksandra Jurisic
    Markovic, Bojana Simovic
    Pantic, Jelena
    Arsenijevic, Nebojsa
    Radosavljevic, Gordana D.
    Nikolic, Maja
    Zornic, Nenad
    Nesic, Jelena
    Muric, Nemanja
    Radmanovic, Branimir
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [10] Schizophrenia, antipsychotics and metabolic disease
    Reynolds, Gavin P.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) : 355 - 356
12345